Progression of eye disease over 15 years in a patient with mucopolysaccharidosis type VI on enzyme replacement therapy
BMJ Case Rep
.
2021 Feb 10;14(2):e238544.
doi: 10.1136/bcr-2020-238544.
Authors
Mohammad Waseem Sarfraz
1
,
Martin Smith
2
,
Simon Jones
3
,
Jane Ashworth
4
Affiliations
1
Ophthalmology, Manchester Royal Eye Hospital, Manchester, Greater Manchester, UK waseem.sarfraz@doctors.org.uk.
2
Optometry, Martin Smith Opticians, Lincoln, Lincolnshire, UK.
3
Willink Metabolic Unit, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK.
4
Ophthalmology, Manchester Royal Eye Hospital, Manchester, Greater Manchester, UK.
PMID:
33568407
PMCID:
PMC7878121
DOI:
10.1136/bcr-2020-238544
No abstract available
Keywords:
metabolic disorders; ophthalmology.
Publication types
Case Reports
MeSH terms
Enzyme Replacement Therapy
Eye Diseases*
Humans
Mucopolysaccharidosis VI* / drug therapy
Recombinant Proteins / therapeutic use
Substances
Recombinant Proteins